Laboratory of Bioengineering and Bioimaging for Osteo-Articular tissues, CNRS, UMR, 7052, Paris, France.
University Paris Diderot, Sorbonne Paris Cité, Paris, France.
Sci Rep. 2018 Nov 20;8(1):17106. doi: 10.1038/s41598-018-35546-6.
Use of human induced pluripotent stem cells (h-iPSCs) for bone tissue engineering is most appealing, because h-iPSCs are an inexhaustible source of osteocompetent cells. The present study investigated the contribution of undifferentiated h-iPSCs and elucidated aspects of the underlying mechanism(s) of the involvement of these cells to new bone formation. Implantation of undifferentiated h-iPSCs seeded on coral particles in ectopic sites of mice resulted in expression of osteocalcin and DMP-1, and in mineral content similar to that of the murine bone. The number of the implanted h-iPSCs decreased with time and disappeared by 30 days post-implantation. In contrast, expression of the murine osteogenic genes at day 15 and 30 post-implantation provided, for the first time, evidence that the implanted h-iPSCs affected the observed outcomes via paracrine mechanisms. Supporting evidence was provided because supernatant conditioned media from h-iPSCs (h-iPSC CM), promoted the osteogenic differentiation of human mesenchymal stem cells (h-MSCs) in vitro. Specifically, h-iPSC CM induced upregulation of the BMP-2, BMP-4 and BMP-6 genes, and promoted mineralization of the extracellular matrix. Given the current interest in the use of h-iPSCs for regenerative medicine applications, our study contributes new insights into aspects of the mechanism underlying the bone promoting capability of h-iPSCs.
利用人诱导多能干细胞(h-iPSCs)进行骨组织工程学最吸引人的地方在于,h-iPSCs 是具有成骨能力细胞的取之不尽的来源。本研究调查了未分化的 h-iPSCs 的贡献,并阐明了这些细胞参与新骨形成的潜在机制的各个方面。将未分化的 h-iPSCs 种植在珊瑚颗粒上,然后植入到小鼠异位部位,结果 h-iPSCs 表达了骨钙素和 DMP-1,并且矿物质含量与小鼠骨相似。植入的 h-iPSCs 的数量随时间减少,在植入后 30 天消失。相比之下,植入后 15 天和 30 天表达的鼠成骨基因首次提供了证据,表明植入的 h-iPSCs 通过旁分泌机制影响了观察到的结果。提供了支持证据,因为 h-iPSCs 的上清液条件培养基(h-iPSC CM)促进了人间充质干细胞(h-MSCs)的体外成骨分化。具体而言,h-iPSC CM 诱导了 BMP-2、BMP-4 和 BMP-6 基因的上调,并促进了细胞外基质的矿化。鉴于目前对 h-iPSCs 用于再生医学应用的兴趣,我们的研究为 h-iPSCs 促进骨形成能力的潜在机制的各个方面提供了新的见解。